Kalkine Media ASX Share Market News & Research
Watchlist Sign Up/Login
https://kalkinemedia.com/resources/assets/public/img/flags/au.png AUS
https://kalkinemedia.com/resources/assets/public/img/flags/nz.png NZ
https://kalkinemedia.com/resources/assets/public/img/flags/uk.png UK
https://kalkinemedia.com/resources/assets/public/img/flags/ca.png CA
https://kalkinemedia.com/resources/assets/public/img/flags/us.png USA
https://kalkinemedia.com/resources/assets/public/img/flags/fr.png FRA
https://kalkinemedia.com/resources/assets/public/img/flags/de.png GER
https://kalkinemedia.com/resources/assets/public/img/flags/es.png ESP
https://kalkinemedia.com/resources/assets/public/img/flags/it.png ITA
https://kalkinemedia.com/resources/assets/public/img/flags/nl.png NLD
https://kalkinemedia.com/resources/assets/public/img/flags/pt.png PRT
https://kalkinemedia.com/resources/assets/public/img/flags/se.png SWE
https://kalkinemedia.com/resources/assets/public/img/flags/gr.png GRC
https://kalkinemedia.com/resources/assets/public/img/flags/in.png IND
https://kalkinemedia.com/resources/assets/public/img/flags/pl.png POL
https://kalkinemedia.com/resources/assets/public/img/flags/br.png BRA
https://kalkinemedia.com/resources/assets/public/img/flags/za.png ZAF
https://kalkinemedia.com/resources/assets/public/img/flags/ru.png RUS
https://kalkinemedia.com/resources/assets/public/img/flags/cn.png CHN
https://kalkinemedia.com/resources/assets/public/img/flags/ae.png UAE
Kalkine Media ASX Share Market News & Research

Echopoint Medical Ltd Appoints Nancy Briefs as Chair of the Board

November 15, 2024 03:10 PM IST | By EIN Presswire
Echopoint Medical Ltd Appoints Nancy Briefs as Chair of the Board
Image source: EIN Presswire

Recent News

thumbnail

Miltenyi Biotec India and BIRAC Sign Letter of Intent to Advance India...

thumbnail

LabPMM® Receives New York State Approval for the NPM1 MRD Assay - Info...

thumbnail

India to Host Inaugural World Technology Summit in 2025

thumbnail

Sensex, Nifty Ease as Most Sectors See Decline in Early Trade

Echopoint Medical Ltd, a med-tech innovator is pleased to announce the appointment of Nancy Briefs as Chair of the Board.

LONDON, LONDON, UNITED KINGDOM, November 15, 2024 /EINPresswire.com/ -- Echopoint Medical Ltd, a med-tech innovator dedicated to addressing gender bias in the diagnosis of ischemia with non-obstructive coronary arteries (INOCA), is pleased to announce the appointment of Nancy Briefs as Chair of the Board. Nancy brings extensive experience in med-tech innovation, strategic growth, and leadership, aligning with Echopoint’s mission of advancing cardiovascular diagnostic solutions.

“We welcome Nancy Briefs as Chair of the Board,” said Antony Odell, CEO of Echopoint Medical Ltd. “Her expertise in medical technology and commitment to healthcare innovation make her an invaluable addition to our team. Nancy’s guidance will be instrumental as Echopoint moves forward with the U.S. launch of iKOr and prepares for clinical trials following FDA market clearance. Her leadership will support our efforts to provide more inclusive, patient-focused diagnostics.”

Nancy Briefs, a respected leader in med-tech with a record of successfully guiding companies through critical growth stages, expressed her commitment to supporting Echopoint’s goals. “I’m honored to join Echopoint at this important juncture,” said Nancy Briefs, Chair of the Board at Echopoint Medical Ltd. “The company’s dedication to addressing gender disparities in cardiovascular health through advanced diagnostics resonates deeply with me. I look forward to working alongside the team to make a meaningful impact on patient care in the U.S. and beyond as we bring iKOr to market.”

Echopoint Medical is actively preparing for the U.S. launch of iKOr, its innovative diagnostic tool for INOCA. With FDA market clearance in place, the company is poised to undertake clinical trials that will further validate iKOr’s effectiveness in real-world settings. This important step reflects Echopoint’s commitment to creating accessible, patient-centered solutions that empower clinicians and improve patient outcomes globally.

About Echopoint Medical Ltd
Echopoint Medical Ltd is a medical technology company headquartered in London, focused on innovative cardiovascular diagnostics. Committed to addressing gender biases in the diagnosis and treatment of INOCA, Echopoint strives to create accessible, patient-centered diagnostic solutions to support clinicians in delivering better outcomes.

For media inquiries, please contact:
Antony Odell
CEO, Echopoint Medical Ltd
Email: [email protected]

Antony Odell
Echopoint Medical Ltd
[email protected]
Visit us on social media:
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (“Kalkine Media, we or us”) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalized advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

Sponsored Articles

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.